GBL Q1 Decline Spurs Strategic Shift Into Ophthalmic & Smart‑City Tech
Groupe Bruxelles Lambert’s Q1 earnings dip fuels a strategic pivot, divesting non‑core assets while acquiring tech‑driven stakes in ophthalmic care and smart‑city traffic management, positioning the firm for long‑term, ESG‑aligned growth amid global…
3 minutes to read


